Lambda VIsion Inc.
- Biotech or pharma, therapeutic R&D
LambdaVision is developing the first photoactive, protein-based artificial retina to restore functional vision to the millions of patients blinded by end-stage retinal degenerative diseases, including retinitis pigmentosa and macular degeneration.